ApoB Goals Are Cost-Effective for Primary Prevention Lipid Therapy
A computer simulation found apoB-guided lipid lowering was cost-effective for primary prevention, outperforming LDL-C and non-HDL-C goals.
Trials, guidelines and practice across cardiovascular medicine.
Trials, guidelines and practice across cardiovascular medicine.